FLIR Launches Second Generation Thermal Camera for Self-Driving Cars and New Thermal Handheld for Automotive Repair
FLIR Systems, Inc. (NASDAQ: FLIR) today announced two thermal imaging cameras for the automotive industry, its next-generation thermal vision Automotive Development Kit (ADK™) for the development of self-driving cars and a handheld diagnostic thermal camera for auto enthusiasts and professionals, the FLIR TG275.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190107005342/en/
FLIR’s second generation all-weather thermal-vision automotive development kit (ADK) augments other autonomous vehicle sensors and offers the redundancy needed to improve safety. (Photo: Business Wire)
FLIR also unveiled a thermal enhanced self-driving test vehicle that demonstrates how thermal cameras improve the safety of advanced driver-assistance systems (ADAS) and fill performance gaps in the autonomous vehicles (AV) of tomorrow. The new cameras and the FLIR thermal autonomous test vehicle will be demonstrated this week at the 2019 Consumer Electronics Show (CES) at the Las Vegas Convention Center, South Hall Three, booth #31166.
Next-Generation FLIR ADK
The next-generation thermal-vision ADK featuring the high-resolution FLIR Boson® thermal camera core is designed to help automakers, tier-one automotive suppliers, and automotive innovators improve the safety of ADAS and self-driving vehicles. Paired with machine-learning algorithms for object classification, the ADK provides critical data from the far infrared portion of the electromagnetic spectrum to improve the decision making of AVs in common environments where other sensors experience challenges, such as darkness, shadows, sun glare, fog, smoke, or haze. The thermal-vision ADK augments the entire sensor suite and offers the redundancy needed to improve safety in AVs.
The new ADK is IP67 rated and now includes an integrated heated window for improved performance in all-weather testing. It also features Gigabit Multimedia Serial Link (GMSL), USB, and Ethernet connection for easier integration. The FLIR ADK is available for purchase at www.flir.com/adk.
FLIR’s Autonomous Test Vehicle
FLIR is also showing the industry’s first thermal camera-equipped commercial test vehicle featuring multiple FLIR ADK cameras that will provide a 360-degree street view. The car demonstrates the ADK’s integration capabilities with radar, LIDAR, and visible cameras found on autonomous test vehicles today. With thermal camera-enhanced automatic emergency braking (AEB), the car helps validate how thermal imaging with machine learning classification improves the functionality of AEB.
“For automated decision making on the roadway, thermal imaging cameras coupled with machine-learning capabilities provide the most effective method for pedestrian detection to save lives, particularly in cluttered environments or in poor visibility,” said Jim Cannon, President and CEO at FLIR. “Furthermore, the FLIR thermal-enhanced autonomous test vehicle demonstrates how thermal cameras can significantly improve urban, highway, and AEB performance and the overall safety of self-driving cars.”
Autonomous car developers interested in more information on the thermal-enhanced test vehicle may visit www.flir.com/adas.
The TG275 is FLIR’s first dedicated thermal camera for automotive technicians and home mechanics. In automobile repair, heat can often mean a potential issue, and the TG275 helps technicians spot problems before they lead to failures, and ultimately a roadside breakdown. Equipped with the FLIR Lepton® thermal microcamera, FLIR’s patented MSX® technology extracts high-contrast details from the images taken by an onboard visible light camera and superimposes them onto the thermal images. Also, the TG275 allows auto repair technicians to reduce diagnostic time and show customers evidence of the problem through before and after images of potential issues.
The TG275 will be available this spring. For additional information, visit www.flir.com/tg275.
About FLIR Systems, Inc.
Founded in 1978 and headquartered in Wilsonville, Oregon, FLIR Systems is a world-leading maker of sensor systems that enhance perception and heighten awareness, helping to save lives, improve productivity, and protect the environment. Through its nearly 3,500 employees, FLIR’s vision is to be “The World’s Sixth Sense” by leveraging thermal imaging and adjacent technologies to provide innovative, intelligent solutions for security and surveillance, environmental and condition monitoring, outdoor recreation, machine vision, navigation, and advanced threat detection. For more information, please visit www.flir.com and follow @flir.
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Fishawack continues to build best-in-class service offering with Dudnyk acquisition20.3.2019 16:00:00 EET | Tiedote
Fishawack, a leading independent healthcare communications specialist, is excited to announce its acquisition of Dudnyk, the Philadelphia-based healthcare communications agency. Dudnyk is an award-winning, full-service agency that specializes in creating insight-driven, authentic brand experiences that unite specialty physicians and their patients. They leverage strategic, scientific, and creative capabilities to serve clients in the biotech, pharmaceutical, and medical device industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190320005204/en/ Dudnyk leadership team includes Christopher Tobias, PhD, President; Laurie Bartolomeo, EVP, Creative Director; Drew Desjardins, EVP, Chief Strategy Officer; Annemarie Armstrong, EVP, Director of Client Services; John Kemble, EVP, Creative Producer. (Photo: Business Wire) Fishawack’s goal is to increase the range of healthcare communications services that it can offer to commerc
ExaGrid Nominated in Six Categories for the 2019 Network Computing Awards20.3.2019 15:00:00 EET | Tiedote
ExaGrid ®, a leading provider of intelligent hyperconverged storage for backup, today announced that it has been nominated in six categories for the 2019 Network Computing Awards. ExaGrid has become a finalist for Data Centre Product of the Year, The Return on Investment Award, Hardware Product of the Year, Product of the Year, The Customer Service Award, and Company of the Year. Voting to determine the winner in each category is underway now and closes on April 23. The results will be revealed at an evening award ceremony in London on May 2. ExaGrid’s model EX63000E backup storage appliance with data deduplication is a nominee in four categories. The model provides the largest scale-out system and offers up to a 2PB full backup with an ingest rate of 432TB/hr, which is three times faster than any other backup storage on the market. “We are thrilled to be nominated by IT staff, and recognized by Network Computing, in six prestigious categories this year,” said Bill Andrews, CEO and Pre
Eos Biosciences Issued Patent for New Approach to Shuttle Therapeutics Across the Blood-Brain Barrier to Treat Brain Diseases20.3.2019 14:30:00 EET | Tiedote
Eos Biosciences, Inc. (Eos), a nanomedicines company developing an efficient and versatile nanobiologic particle-based platform technology (Eosomes), announced that the U.S. Patent and Trademark Office has granted Eos Biosciences Patent No. 10,183,078, relating to a novel approach of using HER3-targeted Eosomes as a shuttle system for transporting various classes of therapeutics across the blood-brain barrier for treatment of brain disorders, including brain cancer. The patent is owned by Cedars-Sinai Medical Center and is exclusively licensed to Eos Biosciences. Details of the system will be highlighted in an upcoming manuscript from Lali Medina-Kauwe, PhD, Professor, Department of Biomedical Sciences, Cedars-Sinai. Omar Haffar, Ph.D., Founder, President and Chief Executive Officer, commented, “We’re very excited by the issuance of this pivotal patent and look forward to receiving similar approvals in other countries. This patent adds to Eos’ considerable IP portfolio covering the Eos
Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics20.3.2019 13:45:00 EET | Tiedote
Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to developing gene therapy treatments for inherited liver disorders with high unmet medical need, and Pfizer Inc. (NYSE: PFE) announced today that Pfizer has acquired a 15% equity interest in Vivet and secured an exclusive option to acquire all outstanding shares. Pfizer and Vivet will collaborate on the development of VTX-801, Vivet’s proprietary treatment for Wilson disease. Wilson disease is a devastating, rare, chronic, and potentially life-threatening liver disorder of impaired copper transport that causes serious copper poisoning. In patients with Wilson disease, a monogenetic mutation disables the normal copper biliary excretion pathway leading to excess copper accumulation in the liver and other organs including the central nervous system. Untreated, Wilson disease results in various combinations and severity of hepatic (fibrosis and cirrhosis), neurologic and psychiatric symptoms, which can b
Fintech Company Rimilia Appoints Kevin Kimber as CEO20.3.2019 13:00:00 EET | Tiedote
Rimilia, a fintech company helping finance departments simplify the complex, has appointed Kevin Kimber as CEO. The news follows another strong year for Rimilia. In 2018, Rimilia opened offices in Central London and Denver, Colorado in the U.S., and reported significant revenue growth on the previous year. Rimilia was founded in 2008 and its platform, created by finance professionals, uses RPA (robotic process automation) technology to help finance teams fast-track their cash flow by providing clearer information and better control. It has quickly become the industry leader, trusted by a number of global brands from HSBC to DHL and Santander, to provide visibility, improve efficiencies and guarantee cash flow. Rimilia works with any currency, any bank and in any language, and on average delivers 70% cost-savings and an 80% reduction in manual effort to its customers. Kevin joins Rimilia from Eight Roads Ventures (one of Rimilia’s investors), where he was a Venture Partner, advising its
Knopp Biosciences Enters Collaboration with Leading UK Investigators to Commence Phase 2 Clinical Trial of Dexpramipexole in Severe Eosinophilic Asthma20.3.2019 13:00:00 EET | Tiedote
Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases with high unmet need, today announced a collaboration with a consortium of leading medical researchers in the United Kingdom to evaluate the ability of Knopp’s lead drug candidate, dexpramipexole, to reduce exacerbations in people with severe eosinophilic asthma. The project is chiefly funded by the National Institute for Health Research (NIHR) and Medical Research Council (MRC) of the UK. The Chief Investigator for the Phase 2 multi-center, 52-week trial is Professor Salman Siddiqui, Professor of Airway Diseases at the University of Leicester and Consultant Respiratory Physician at Leicester’s Hospitals. Dexpramipexole is an orally available small molecule shown to selectively reduce eosinophil levels in multiple clinical trials, including in a Phase 2 study in hypereosinophilic syndrome (HES) and a Phase 2 trial in chr
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme